Pharmacokinetics, Trypanosoma brucei gambiense Efficacy, and Time of Drug Action of DB829, a Preclinical Candidate for Treatment of Second-Stage Human African Trypanosomiasis

Human African trypanosomiasis (HAT, also called sleeping sickness), a neglected tropical disease endemic to sub-Saharan Africa, is caused by the parasites Trypanosoma brucei gambiense and T. brucei rhodesiense. Current drugs against this disease have significant limitations, including toxicity, incr...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Wenzler, Tanja, Yang, Sihyung, Braissant, Olivier, Boykin, David W., Brun, Reto, Wang, Michael Zhuo
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2013
Témata:
Experimental Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3811327/
https://ncbi.nlm.nih.gov/pubmed/23959303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00398-13
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky